GNH USA

Europe — EMA

Leukeran (Chlorambucil)

GNH USA supplies Leukeran (Chlorambucil), an alkylating agent for chronic lymphocytic leukemia and Hodgkin's lymphoma. Request a quote for global supply.

Chlorambucil

Request sourcing

1
Pack/s

What is Chlorambucil?

Chlorambucil, the active ingredient in Leukeran, is an alkylating agent (nitrogen mustard) presented as an oral formulation for systemic use. It is employed in the treatment of chronic lymphocytic leukemia, Hodgkin's lymphoma, and other lymphoid malignancies, primarily in adult patients.

GNH USA supplies Leukeran as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, oncology centres, pharmacies and clinics worldwide across multiple regulatory markets.

What is Chlorambucil used for?

Leukeran (chlorambucil) is used in hematologic cancers where DNA alkylation is required to control malignant cell proliferation.

Chronic lymphocytic leukemia (CLL): reduces leukemic cell count and prolongs survival. Hodgkin's lymphoma: induces remission by targeting proliferating lymphoid cells. Other lymphoid malignancies: provides disease control in selected non‑Hodgkin lymphomas and related disorders.

What are the side effects of Chlorambucil?

Chlorambucil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting - Diarrhea - Fatigue or weakness - Mild bone‑marrow suppression (e.g., transient leukopenia)

Serious or Rare Side Effects: - Severe myelosuppression (profound neutropenia, anemia, thrombocytopenia) - Secondary malignancies (e.g., acute leukemia) - Severe gastrointestinal ulceration or hemorrhage - Pulmonary toxicity (interstitial pneumonitis)

What precautions apply to Chlorambucil?

When prescribing or handling Leukeran, several precautions should be observed to minimize risks. - Monitor blood counts: perform regular complete blood count (CBC) assessments to detect myelosuppression. - Assess liver and kidney function: adjust therapy if hepatic or renal impairment is present. - Avoid use in patients with active infections: postpone treatment until infection resolves. - Counsel on contraception: advise women of childbearing potential to use effective contraception during therapy and for a defined period after cessation. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

What does Chlorambucil interact with?

Chlorambucil can interact with other medicines, altering its efficacy or toxicity.

Major Interactions (Avoid): - Concurrent use with other alkylating agents: may cause additive bone‑marrow suppression. - Strong CYP2D6 inhibitors (e.g., fluoxetine): can increase chlorambucil plasma levels. - Live vaccines: immunosuppression may reduce vaccine efficacy and increase infection risk.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): enhanced bleeding risk due to mucosal toxicity. - Allopurinol: may increase risk of myelosuppression. - NSAIDs: can exacerbate gastrointestinal irritation and ulceration.

Frequently asked questions

What is Leukeran used for?+
Leukeran, whose active ingredient is chlorambucil, is indicated for the treatment of chronic lymphocytic leukemia, Hodgkin's lymphoma, and selected other lymphoid malignancies. It is used in adult patients to control disease progression by targeting rapidly dividing cancer cells.
How does chlorambucil work?+
Chlorambucil belongs to the nitrogen‑mustard class of alkylating agents. It forms covalent bonds with DNA, creating cross‑links that block DNA replication and transcription. This DNA damage leads to cell‑cycle arrest and apoptosis, especially in fast‑growing lymphoid cancer cells.
What is the usual dose of Leukeran?+
The specific dose of Leukeran is individualized by the prescribing physician based on the patient’s diagnosis, disease stage, body surface area, renal and hepatic function, and tolerance. Only a qualified healthcare professional should determine the appropriate dosing regimen.
Is Leukeran safe during pregnancy or breastfeeding?+
Chlorambucil is classified as a teratogenic agent and may cause fetal harm. It is generally contraindicated during pregnancy and should be avoided while breastfeeding. Women of childbearing potential should use effective contraception throughout treatment and for a period after discontinuation as advised by their physician.
How do I order Leukeran from GNH USA?+
To order Leukeran, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Leukeran compare with other alkylating agents?+
Leukeran (chlorambucil) is an oral nitrogen‑mustard with a relatively long half‑life, allowing once‑daily dosing in many protocols. Compared with intravenous agents such as cyclophosphamide, it offers convenience of oral administration but may have a higher incidence of gastrointestinal irritation. Efficacy and safety profiles are comparable when used for approved indications.
How should Leukeran be stored and handled?+
Leukeran tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use. Follow standard good‑manufacturing practices when handling the medication.
How is Leukeran administered?+
Leukeran is administered orally, usually as a tablet taken with water. The exact dosing schedule—such as daily or on specific days of a treatment cycle—is determined by the treating physician based on the patient’s clinical condition and response to therapy.
What are the most serious risks to watch for while taking Leukeran?+
The most serious risks include severe myelosuppression (leading to neutropenia, anemia, or thrombocytopenia), secondary malignancies such as acute leukemia, and serious gastrointestinal complications like ulceration or bleeding. Patients should be monitored regularly for blood‑count changes and any signs of infection or bleeding.
Who should not use Leukeran?+
Leukeran should be avoided in patients with known hypersensitivity to chlorambucil or other nitrogen‑mustard agents, in those with active severe infections, and in pregnant or nursing women unless the benefits outweigh the risks. Caution is also advised for individuals with significant hepatic or renal impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Chlorambucil
Route
Oral Use
Manufacturer
Aspen Pharma Trading Limited
Origin
EU

Related products

Leukeran 2 mg

Leukeran 2 mg

Chlorambucil · 2 MG

Leukeran
TABLET
ASPEN PHARMACARE CANADA INC.
CANADA
Chlorambucil Aspen

Chlorambucil Aspen

Chlorambucil

Aspen Pharma Trading Limited
EU
Chloraminophene

Chloraminophene

Chlorambucil

Techni-Pharma
EU
Clorambucilo Aspen

Clorambucilo Aspen

Chlorambucil

Aspen Pharma Trading Limited
EU